Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
クイックコネクト

ホワイトペーパー

Product Alert – Niraparib API

2023

Product Alert – Niraparib API

Product Alert – Tucatinib API

2023

Product Alert – Tucatinib API

Product Alert – Relugolix API

2023

Product Alert – Relugolix API

Product Alert – Pazopanib API

2023

Product Alert – Pazopanib API

Tech Sheet on Midostaurin API

2023

Tech Sheet on Midostaurin API

Tech Sheet on Tofacitinib Citrate

2023

Tech Sheet on Tofacitinib Citrate

Tech Sheet on Ibrutinib

2022

Tech Sheet on Ibrutinib

Tech Sheet on Linagliptin

2022

Tech Sheet on Linagliptin

Tech Sheet on Dutasteride

2022

Tech Sheet on Dutasteride

New Product Alert – Ruxolitinib Phosphate

2022

New Product Alert – Ruxolitinib Phosphate

Tech Sheet on Voriconazole

2022

Tech Sheet on Voriconazole

Tech Sheet on Nilotinib Hydrochloride

2022

Tech Sheet on Nilotinib Hydrochloride

Addressing the presence of mutagenic Azido impurities in Sartan APIs

2022

Addressing the presence of mutagenic Azido impurities in Sartan APIs

Co-Crystal and Customized Particle Size for Early Launch Opportunity of Siponimod API

2022

Co-Crystal and Customized Particle Size for Early Launch Opportunity of Siponimod API

New Product Alert – Lumateperone Tosylate API

2022

New Product Alert – Lumateperone Tosylate API

Tech sheet: Dr. Reddy's Bempedoic Acid API Offerings

2022

Tech sheet: Dr. Reddy's Bempedoic Acid API Offerings

Tech sheet: Dr. Reddys Olaparib API Offerings

2022

Tech sheet: Dr. Reddy's Olaparib API Offerings

Tech sheet: Dr. Reddy's Enzalutamide API Offerings

2022

Tech sheet: Dr. Reddy's Enzalutamide API Offerings

Semaglutide - Dr. Reddy’s Fully Synthetic Peptide API

2022

Semaglutide - Dr. Reddy’s Fully Synthetic Peptide API

Our Peptide API Capabilities and Services throughout the product life cycle

2022

Our Peptide API Capabilities and Services throughout the product life cycle

Tech Sheet - Dr. Reddy’s Eribulin Mesylate API offerings

2022

Tech Sheet - Dr. Reddy’s Eribulin Mesylate API offerings

Tech Sheet – Dr. Reddy’s Fexofenadine API offerings

2022

Tech Sheet – Dr. Reddy’s Fexofenadine API offerings

Tech Sheet - Dr. Reddy’s Azacitidine API offerings

2022

Tech Sheet - Dr. Reddy’s Azacitidine API offerings

Tech Sheet - Dr. Reddy’s Ramipril API offerings

2022

Tech Sheet - Dr. Reddy’s Ramipril API offerings

Tech Sheet - Dr. Reddy’s Gemcitabine API offerings

2021

Tech Sheet - Dr. Reddy’s Gemcitabine API offerings

Tech Sheet: Dr. Reddy’s Abiraterone Acetate API offerings

2021

Tech Sheet: Dr. Reddy’s Abiraterone Acetate API offerings

Remdesivir

2021

White Paper: Redyx: Remdesivir formulation developed at Dr. Reddy’s under the license from Gilead

Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients

2021

Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients

Techsheet: Dr.Reddy's Lenvatinib API offerings

2021

Techsheet: Dr.Reddy's Lenvatinib API offerings

ROXADUSTAT - a multipronged development strategy

2021

ROXADUSTAT - a multipronged development strategy

Dr.Reddy's Apremilast API and finished formulation offerings.

2021

Dr.Reddy's Apremilast API and finished formulation offerings.

Dr. Reddy’s Fosaprepitant API offerings

2021

Dr. Reddy’s Fosaprepitant API offerings

Apixaban API – ready-to-compress granules and finished dosage forms

2021

Apixaban API – ready-to-compress granules and finished dosage forms

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

2021

Apalutamide API – an attractive NCE-1 opportunity for generic pharma companies

Colloidal Iron Complex Formulations – Understanding and Developing the Process

2021

Colloidal Iron Complex Formulations – Understanding and Developing the Process

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

2021

Rivaroxaban from Dr.Reddy’s: Full basket offerings of API and Finished formulations

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

2021

Dr. Reddy's Mirabegron API offering in both alpha and amorphous form

Palbociclib – how a novel process development approach provides IP advantages

2021

Palbociclib – how a novel process development approach provides IP advantages

Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach

2020

Dr. Reddy's Elagolix API offering leverages a well rounded Quality by Design approach

Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings

2020

Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings

Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today

2020

Dr. Reddy’s Flow Chemistry experts share their perspectives in panel discussion of Chemistry Today

A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine

2020

A closer look on how Dr. Reddy's met the stringent regulatory requirement of genotoxic impurities in Ranolazine

Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security

2020

Famotidine and Nizatidine APIs: NDMA controlled, customized particle distribution, supply chain security

Sugammadex Sodium – The impact of an integrated understanding from API to formulation on injectable formulation success

2020

Sugammadex Sodium – The impact of an integrated understanding from API to formulation on injectable formulation success

Meeting the New Regulatory Requirements in Sartan API Production

2019

Meeting the New Regulatory Requirements in Sartan API Production

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit